Myxoedema Coma
Myxoedema Coma is a rare, serious complication of long-standing underactive thyroid where the body’s functions slow to a dangerous level. It needs urgent hospital treatment.
Key points
- Myxoedema Coma most often develops in people with long-standing, untreated underactive thyroid, particularly older adults.
- The listed product contains Liothyronine, a synthetic thyroid hormone.
Common questions about Myxoedema Coma
Which medicines are listed for Myxoedema Coma?
Myxoedema Coma is a severe complication of long-standing underactive thyroid, and the catalogue contains one product, Cytomel, which holds the ingredient Liothyronine, a synthetic form of the thyroid hormone the body needs. Liothyronine
What kind of medicine is used for Myxoedema Coma?
The listed product belongs to the thyroid hormone replacement class. It supplies the hormone that an underactive thyroid can no longer make in sufficient amounts to meet the body’s needs.
